Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ExOne CoXONE · Entity 133431 | See Remarks | August 14, 2017 | August 15, 2017 |
| Viatris IncVTRS · Entity 3277 | Director | March 06, 2026 | March 10, 2026 |
| WORLD WRESTLING ENTERTAINMENT, LLCWWE · Entity 109803 | Director | January 03, 2023 | January 03, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ExOne Co
Report date August 14, 2017 · Filed August 15, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 45,000 |
Reported balance
After 2017-08-14 transaction · row 1
1 source rowRow 1 · 2017-08-14 · Grant · Acquired 15,000 · Balance 45,000 F1: Grant of restricted stock under The ExOne Company 2013 Equity Incentive Plan. The restricted stock vests 100% on date of grant. |
| Common StockSEC Table I · non-derivative | IndirectBy trust | 20,000 |
Reported balance
Holding disclosure · report date 2017-08-14 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 20,000 F2: These shares are held directly by the Lyons 2012 Trust. |
| Common StockSEC Table I · non-derivative | IndirectBy limited partnership | 13,500 |
Reported balance
Holding disclosure · report date 2017-08-14 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 13,500 F3: These shares are held directly by DWD Holdings LP. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of restricted stock under The ExOne Company 2013 Equity Incentive Plan. The restricted stock vests 100% on date of grant.
F2: These shares are held directly by the Lyons 2012 Trust.
F3: These shares are held directly by DWD Holdings LP.
Viatris Inc
Report date March 06, 2026 · Filed March 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 102,526 |
Ending reported balance
After 2026-03-06 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-03-06 · Exercise / conversion · Acquired 23,660 · Balance 101,351 Row 2 · 2026-03-06 · Exercise / conversion · Acquired 1,175 · Balance 102,526 F1: Fractional shares have been rounded up in connection with the settlement described in footnote 3 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-03-06 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-03-06 · Exercise / conversion · Disposed 23,660 · Balance 0 F2: Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs vested in full on March 6, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 15,890 |
Reported balance
After 2026-03-06 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-03-06 · Grant · Acquired 15,890 · Balance 15,890 F4: Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs will vest on March 6, 2027. |
| Dividend Equivalent UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-03-06 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-03-06 · Exercise / conversion · Disposed 1,174.4921 · Balance 0 F3: Represents dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 6, 2025 and vested on the same schedule as the underlying RSUs. Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11. |
| Common StockSEC Table I · non-derivative | IndirectBy Spouse | 18 |
Reported balance
Holding disclosure · report date 2026-03-06 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 18 |
Filing footnotes · ownership attribution and instrument terms
F1: Fractional shares have been rounded up in connection with the settlement described in footnote 3 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan.
F2: Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs vested in full on March 6, 2026.
F3: Represents dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 6, 2025 and vested on the same schedule as the underlying RSUs. Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11.
F4: Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs will vest on March 6, 2027.
WORLD WRESTLING ENTERTAINMENT, LLC
Report date January 03, 2023 · Filed January 03, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 426 |
Reported balance
After 2023-01-03 transaction · row 1
1 source rowRow 1 · 2023-01-03 · Grant · Acquired 365 · Balance 426 F1: These shares were received in lieu of cash as a portion of the filer's director's fees. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were received in lieu of cash as a portion of the filer's director's fees.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Mylan II B.V.
Report date November 16, 2020 · Filed November 18, 2020
Section 16 reporting ended · disclosed 2020-11-18. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2020-11-16 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2020-11-16 · Disposition to issuer · Disposed 15,609 · Balance 0 F1: On November 16, 2020, Mylan N.V. ("Mylan") completed the transaction pursuant to which Mylan combined with Pfizer Inc.'s ("Pfizer") Upjohn business (the "Upjohn Business") in a Reverse Morris Trust transaction (the "Combination") and Upjohn Inc. ("Upjohn") became the parent entity of the combined Upjohn Business and Mylan business and was renamed "Viatris Inc." ("Viatris"). Pursuant to the terms of the Business Combination Agreement (as amended), dated July 29, 2019, by and among Mylan, Pfizer, Upjohn and certain other affiliated entities, Upjohn and Mylan effected the Combination through a series of transactions, including that (1) Mylan merged with and into Mylan II B.V. with Mylan II B.V. surviving the merger as the legal successor of Mylan and (2) each holder of Mylan ordinary shares received one share of Viatris common stock for each Mylan ordinary share held by such holder (subject to any required withholding tax). F2: Represents ordinary shares of Mylan that were exchanged on a one-for-one basis for shares of Viatris common stock in connection with the Combination. On the effective date of the Combination, the closing price of a Mylan ordinary share was $15.85 per share. |
| Non-Employee Director Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $45.72 · Expires 2024-04-11 | Direct | 0 |
Reported balance
After 2020-11-16 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2020-11-16 · Disposition to issuer · Disposed 2,974 · Balance 0 F3: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F4: These options vested on April 11, 2015. |
| Non-Employee Director Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $50.66 · Expires 2025-11-17 | Direct | 0 |
Reported balance
After 2020-11-16 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2020-11-16 · Disposition to issuer · Disposed 2,603 · Balance 0 F3: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F5: These options vested on May 1, 2016. |
| Non-Employee Director Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $46.27 · Expires 2026-02-17 | Direct | 0 |
Reported balance
After 2020-11-16 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2020-11-16 · Disposition to issuer · Disposed 2,788 · Balance 0 F3: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F6: These options vested on February 17, 2017. |
| Non-Employee Director Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $45.18 · Expires 2027-03-03 | Direct | 0 |
Reported balance
After 2020-11-16 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2020-11-16 · Disposition to issuer · Disposed 2,928 · Balance 0 F3: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F7: These options vested on March 3, 2018. |
| Non-Employee Director Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $40.97 · Expires 2028-03-02 | Direct | 0 |
Reported balance
After 2020-11-16 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2020-11-16 · Disposition to issuer · Disposed 2,984 · Balance 0 F3: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F8: These options vested on March 2, 2019. |
| Non-Employee Director Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $27.45 · Expires 2029-03-01 | Direct | 0 |
Reported balance
After 2020-11-16 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2020-11-16 · Disposition to issuer · Disposed 4,352 · Balance 0 F3: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F9: These options vested on March 2, 2020. |
| Non-Employee Director Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $17.48 · Expires 2030-03-02 | Direct | 0 |
Reported balance
After 2020-11-16 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2020-11-16 · Disposition to issuer · Disposed 6,151 · Balance 0 F3: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F10: These options will vest on March 2, 2021. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2020-11-16 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2020-11-16 · Disposition to issuer · Disposed 9,440 · Balance 0 F11: Represents restricted stock units ("RSUs") of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms in connection with the Combination. F12: Each RSU represents the right to receive one ordinary share of Mylan. The RSUs will vest on March 2, 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: On November 16, 2020, Mylan N.V. ("Mylan") completed the transaction pursuant to which Mylan combined with Pfizer Inc.'s ("Pfizer") Upjohn business (the "Upjohn Business") in a Reverse Morris Trust transaction (the "Combination") and Upjohn Inc. ("Upjohn") became the parent entity of the combined Upjohn Business and Mylan business and was renamed "Viatris Inc." ("Viatris"). Pursuant to the terms of the Business Combination Agreement (as amended), dated July 29, 2019, by and among Mylan, Pfizer, Upjohn and certain other affiliated entities, Upjohn and Mylan effected the Combination through a series of transactions, including that (1) Mylan merged with and into Mylan II B.V. with Mylan II B.V. surviving the merger as the legal successor of Mylan and (2) each holder of Mylan ordinary shares received one share of Viatris common stock for each Mylan ordinary share held by such holder (subject to any required withholding tax).
F2: Represents ordinary shares of Mylan that were exchanged on a one-for-one basis for shares of Viatris common stock in connection with the Combination. On the effective date of the Combination, the closing price of a Mylan ordinary share was $15.85 per share.
F3: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination.
F4: These options vested on April 11, 2015.
F5: These options vested on May 1, 2016.
F6: These options vested on February 17, 2017.
F7: These options vested on March 3, 2018.
F8: These options vested on March 2, 2019.
F9: These options vested on March 2, 2020.
F10: These options will vest on March 2, 2021.
F11: Represents restricted stock units ("RSUs") of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms in connection with the Combination.
F12: Each RSU represents the right to receive one ordinary share of Mylan. The RSUs will vest on March 2, 2021.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 06, 2026 Filed Mar 10, 2026 19:03 UTC | Viatris Inc VTRS · Entity 3277 | GrantRestricted Stock Units · Derivative | 15,890 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-26-008878 · form4.xml · derivative · entry 6 Lyons Dillon JoEllen · CIK 0001570168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,890 Underlying: Common Stock · 15,890 shares Expires not disclosed F4 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs will vest on March 6, 2027. F4 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs will vest on March 6, 2027. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 19:03 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionDividend Equivalent Units · Derivative | 1,174.4921 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-26-008878 · form4.xml · derivative · entry 5 Lyons Dillon JoEllen · CIK 0001570168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,174.4921 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Represents dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 6, 2025 and vested on the same schedule as the underlying RSUs. Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11. F3 · derivative.expiration_date: Represents dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 6, 2025 and vested on the same schedule as the underlying RSUs. Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 19:03 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionRestricted Stock Units · Derivative | 23,660 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-26-008878 · form4.xml · derivative · entry 4 Lyons Dillon JoEllen · CIK 0001570168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,660 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs vested in full on March 6, 2026. F2 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs vested in full on March 6, 2026. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 19:03 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 1,175 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-26-008878 · form4.xml · nonDerivative · entry 2 Lyons Dillon JoEllen · CIK 0001570168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,526 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Fractional shares have been rounded up in connection with the settlement described in footnote 3 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 19:03 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 23,660 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-26-008878 · form4.xml · nonDerivative · entry 1 Lyons Dillon JoEllen · CIK 0001570168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,351 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 18:00 UTC | Viatris Inc VTRS · Entity 3277 | GrantRestricted Stock Units · Derivative | 23,660 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-036577 · ownership.xml · derivative · entry 1 Lyons Dillon JoEllen · CIK 0001570168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,660 Underlying: Common Stock · 23,660 shares Expires not disclosed F1 · derivative.exercise_date: Each restricted stock unit (RSU) represents the right to receive one share of common stock of Viatris Inc. These RSUs will vest on March 6, 2026. F1 · derivative.expiration_date: Each restricted stock unit (RSU) represents the right to receive one share of common stock of Viatris Inc. These RSUs will vest on March 6, 2026. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 19:00 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionDividend Equivalent Units · Derivative | 772.8421 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-034007 · ownership.xml · derivative · entry 5 Lyons Dillon JoEllen · CIK 0001570168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 772.8421 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Represents dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 4, 2024 and vested on the same schedule as the underlying RSUs. Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11. F3 · derivative.expiration_date: Represents dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 4, 2024 and vested on the same schedule as the underlying RSUs. Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 19:00 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionRestricted Stock Units · Derivative | 18,204 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-034007 · ownership.xml · derivative · entry 4 Lyons Dillon JoEllen · CIK 0001570168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,204 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs vested in full on March 4, 2025. F2 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs vested in full on March 4, 2025. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 19:00 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 773 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-034007 · ownership.xml · nonDerivative · entry 2 Lyons Dillon JoEllen · CIK 0001570168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,691 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Fractional shares have been rounded up in connection with the settlement described in footnote 3 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 19:00 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 18,204 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-034007 · ownership.xml · nonDerivative · entry 1 Lyons Dillon JoEllen · CIK 0001570168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,918 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2024 Filed Mar 5, 2024 20:19 UTC | Viatris Inc VTRS · Entity 3277 | SaleCommon Stock | 20,000 | $12.36 | $247,200.00 |
DisclosureSEC source: 0000950170-24-026658 · ownership.xml · nonDerivative · entry 3 Lyons Dillon JoEllen · CIK 0001570168 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,714 F2 · security: These shares of common stock were sold pursuant to a written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, that was adopted by the reporting person on November 28, 2023. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 20:19 UTC | Viatris Inc VTRS · Entity 3277 | GrantRestricted Stock Units · Derivative | 18,204 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-026658 · ownership.xml · derivative · entry 7 Lyons Dillon JoEllen · CIK 0001570168 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,204 Underlying: Common Stock · 18,204 shares Expires not disclosed F5 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. These RSUs will vest on March 4, 2025. F5 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. These RSUs will vest on March 4, 2025. Read SEC document |
| March 03, 2024 Filed Mar 5, 2024 20:19 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionDividend Equivalent Units · Derivative | 884.8005 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-026658 · ownership.xml · derivative · entry 6 Lyons Dillon JoEllen · CIK 0001570168 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 884.8005 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Represents dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 3, 2023 and vested on the same schedule as the underlying RSUs. Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11. F4 · derivative.expiration_date: Represents dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 3, 2023 and vested on the same schedule as the underlying RSUs. Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11. Read SEC document |
| March 03, 2024 Filed Mar 5, 2024 20:19 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionRestricted Stock Units · Derivative | 17,970 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-026658 · ownership.xml · derivative · entry 5 Lyons Dillon JoEllen · CIK 0001570168 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,970 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). These RSUs vested in full on March 3, 2024. F3 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). These RSUs vested in full on March 3, 2024. Read SEC document |
| March 03, 2024 Filed Mar 5, 2024 20:19 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 885 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-026658 · ownership.xml · nonDerivative · entry 2 Lyons Dillon JoEllen · CIK 0001570168 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 78,714 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Fractional shares have been rounded up in connection with the settlement described in footnote 4 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan. Read SEC document |
| March 03, 2024 Filed Mar 5, 2024 20:19 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 17,970 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-026658 · ownership.xml · nonDerivative · entry 1 Lyons Dillon JoEllen · CIK 0001570168 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 77,829 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 04, 2023 Filed Mar 6, 2023 19:01 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionDividend Equivalent Units · Derivative | 704.8417 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-007226 · doc4.xml · derivative · entry 6 Lyons Dillon JoEllen · CIK 0001570168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 704.8417 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Represents dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 4, 2022 and vested on the same schedule as the underlying RSUs. On May 6, 2022, Viatris filed a registration statement on Form S-3 with respect to its Dividend Reinvestment and Share Purchase Plan; amount represents DEUs that subsequently accrued with respect to such RSUs in June 2022, September 2022 and December 2022 in transactions exempt from Section 16 under Rule 16a-11. F4 · derivative.expiration_date: Represents dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 4, 2022 and vested on the same schedule as the underlying RSUs. On May 6, 2022, Viatris filed a registration statement on Form S-3 with respect to its Dividend Reinvestment and Share Purchase Plan; amount represents DEUs that subsequently accrued with respect to such RSUs in June 2022, September 2022 and December 2022 in transactions exempt from Section 16 under Rule 16a-11. Read SEC document |
| March 04, 2023 Filed Mar 6, 2023 19:01 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionRestricted Stock Units · Derivative | 19,608 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-007226 · doc4.xml · derivative · entry 5 Lyons Dillon JoEllen · CIK 0001570168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,608 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. These RSUs vested in full on March 4, 2023. F3 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. These RSUs vested in full on March 4, 2023. Read SEC document |
| March 04, 2023 Filed Mar 6, 2023 19:01 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 705 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-007226 · doc4.xml · nonDerivative · entry 2 Lyons Dillon JoEllen · CIK 0001570168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,859 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Fractional shares have been rounded up in connection with the settlement described in footnote 4 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan. Read SEC document |
| March 04, 2023 Filed Mar 6, 2023 19:01 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 19,608 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-007226 · doc4.xml · nonDerivative · entry 1 Lyons Dillon JoEllen · CIK 0001570168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,154 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2023 Filed Mar 6, 2023 19:01 UTC | Viatris Inc VTRS · Entity 3277 | GrantRestricted Stock Units · Derivative | 17,970 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-007226 · doc4.xml · derivative · entry 4 Lyons Dillon JoEllen · CIK 0001570168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,970 Underlying: Common Stock · 17,970 shares Expires not disclosed F2 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). These RSUs will vest on March 3, 2024. F2 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). These RSUs will vest on March 3, 2024. Read SEC document |
| January 03, 2023 Filed Jan 3, 2023 16:43 UTC | WORLD WRESTLING ENTERTAINMENT, LLC WWE · Entity 109803 | GrantClass A Common Stock | 365 | $0.00 | $0.00 |
DisclosureSEC source: 0001091907-23-000008 · edgar.xml · nonDerivative · entry 1 Lyons Dillon JoEllen · CIK 0001570168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 426 F1 · price: These shares were received in lieu of cash as a portion of the filer's director's fees. Read SEC document |
| October 03, 2022 Filed Oct 4, 2022 16:19 UTC | WORLD WRESTLING ENTERTAINMENT, LLC WWE · Entity 109803 | GrantClass A Common Stock | 61 | $0.00 | $0.00 |
DisclosureSEC source: 0001091907-22-000111 · edgar.xml · nonDerivative · entry 1 Lyons Dillon JoEllen · CIK 0001570168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61 F1 · price: These shares were received in lieu of cash as a portion of the filer's director's fees. Read SEC document |
| March 21, 2022 Filed Mar 23, 2022 19:00 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionDividend Equivalent Units · Derivative | 165.5224 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-011984 · doc4.xml · derivative · entry 4 Lyons Dillon JoEllen · CIK 0001570168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 165.5224 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Represents dividend equivalent units (DEUs) that accrued with respect to RSUs previously granted on March 2, 2021. The DEUs vested upon accrual as the underlying RSUs had previously vested. F2 · derivative.expiration_date: Represents dividend equivalent units (DEUs) that accrued with respect to RSUs previously granted on March 2, 2021. The DEUs vested upon accrual as the underlying RSUs had previously vested. Read SEC document |
| March 21, 2022 Filed Mar 23, 2022 19:00 UTC | Viatris Inc VTRS · Entity 3277 | GrantDividend Equivalent Units · Derivative | 165.5224 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-011984 · doc4.xml · derivative · entry 3 Lyons Dillon JoEllen · CIK 0001570168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165.5224 Underlying: Common Stock · 165.5224 shares Expires not disclosed F2 · derivative.exercise_price: Represents dividend equivalent units (DEUs) that accrued with respect to RSUs previously granted on March 2, 2021. The DEUs vested upon accrual as the underlying RSUs had previously vested. F2 · derivative.exercise_date: Represents dividend equivalent units (DEUs) that accrued with respect to RSUs previously granted on March 2, 2021. The DEUs vested upon accrual as the underlying RSUs had previously vested. F2 · derivative.expiration_date: Represents dividend equivalent units (DEUs) that accrued with respect to RSUs previously granted on March 2, 2021. The DEUs vested upon accrual as the underlying RSUs had previously vested. Read SEC document |
| March 21, 2022 Filed Mar 23, 2022 19:00 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 166 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-011984 · doc4.xml · nonDerivative · entry 1 Lyons Dillon JoEllen · CIK 0001570168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,546 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Fractional shares have been rounded up in connection with the settlement described in footnote 2 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan. Read SEC document |
| March 04, 2022 Filed Mar 4, 2022 20:13 UTC | Viatris Inc VTRS · Entity 3277 | GrantRestricted Stock Units · Derivative | 19,608 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-009567 · doc4.xml · derivative · entry 6 Lyons Dillon JoEllen · CIK 0001570168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,608 Underlying: Common Stock · 19,608 shares Expires not disclosed F4 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. These RSUs will vest on March 4, 2023. F4 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. These RSUs will vest on March 4, 2023. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 20:13 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionDividend Equivalent Units · Derivative | 334.4826 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-009567 · doc4.xml · derivative · entry 5 Lyons Dillon JoEllen · CIK 0001570168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 334.4826 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Represents dividend equivalent units that accrued with respect to the RSUs previously granted on March 2, 2021 and vested on the same schedule as the underlying RSUs. F3 · derivative.expiration_date: Represents dividend equivalent units that accrued with respect to the RSUs previously granted on March 2, 2021 and vested on the same schedule as the underlying RSUs. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 20:13 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionRestricted Stock Units · Derivative | 13,996 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-009567 · doc4.xml · derivative · entry 4 Lyons Dillon JoEllen · CIK 0001570168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,996 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). These RSUs vested in full on March 2, 2022. F2 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). These RSUs vested in full on March 2, 2022. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 20:13 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 335 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-009567 · doc4.xml · nonDerivative · entry 2 Lyons Dillon JoEllen · CIK 0001570168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,380 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Fractional shares have been rounded up in connection with the settlement described in footnote 3 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 20:13 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 13,996 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-009567 · doc4.xml · nonDerivative · entry 1 Lyons Dillon JoEllen · CIK 0001570168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,045 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 21, 2021 Filed Dec 23, 2021 18:01 UTC | Viatris Inc VTRS · Entity 3277 | GrantDividend Equivalent Units · Derivative | 120.0574 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-049639 · doc4.xml · derivative · entry 1 Lyons Dillon JoEllen · CIK 0001570168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 334.4826 Underlying: Common Stock · 120.0574 shares Expires not disclosed F1 · derivative.exercise_price: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. F1 · derivative.exercise_date: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. F1 · derivative.expiration_date: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. Read SEC document |
| September 22, 2021 Filed Sep 24, 2021 18:00 UTC | Viatris Inc VTRS · Entity 3277 | GrantDividend Equivalent Units · Derivative | 113.2715 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-037658 · doc4.xml · derivative · entry 1 Lyons Dillon JoEllen · CIK 0001570168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214.4252 Underlying: Common Stock · 113.2715 shares Expires not disclosed F1 · derivative.exercise_price: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. F1 · derivative.exercise_date: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. F1 · derivative.expiration_date: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. Read SEC document |
| June 21, 2021 Filed Jun 23, 2021 20:35 UTC | Viatris Inc VTRS · Entity 3277 | GrantDividend Equivalent Units · Derivative | 101.1537 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-025589 · doc4.xml · derivative · entry 1 Lyons Dillon JoEllen · CIK 0001570168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101.1537 Underlying: Common Stock · 101.1537 shares Expires not disclosed F1 · derivative.exercise_price: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. F1 · derivative.exercise_date: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. F1 · derivative.expiration_date: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 18:36 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionRestricted Stock Units · Derivative | 9,440 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-009938 · doc4.xml · derivative · entry 4 Lyons Dillon JoEllen · CIK 0001570168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,440 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. These RSUs vested in full on March 2, 2021. F2 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. These RSUs vested in full on March 2, 2021. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 18:36 UTC | Viatris Inc VTRS · Entity 3277 | GrantRestricted Stock Units · Derivative | 13,996 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-009938 · doc4.xml · derivative · entry 3 Lyons Dillon JoEllen · CIK 0001570168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,996 Underlying: Common Stock · 13,996 shares Expires not disclosed F1 · derivative.exercise_date: Each restricted stock unit (RSU) represents the right to receive one share of common stock of Viatris Inc. ("Viatris"). These RSUs will vest on March 2, 2022. F1 · derivative.expiration_date: Each restricted stock unit (RSU) represents the right to receive one share of common stock of Viatris Inc. ("Viatris"). These RSUs will vest on March 2, 2022. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 18:36 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 9,440 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-009938 · doc4.xml · nonDerivative · entry 1 Lyons Dillon JoEllen · CIK 0001570168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,049 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:52 UTC | Viatris Inc VTRS · Entity 3277 | GrantRestricted Stock Units · Derivative | 9,440 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000899243-20-031576 · doc4.xml · derivative · entry 10 Lyons Dillon JoEllen · CIK 0001570168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,440 Underlying: Common Stock · 9,440 shares Expires not disclosed F12 · security: Received in exchange for, and having substantially the same terms as, restricted stock units ("RSUs") of Mylan in connection with the Combination. F12 · price: Received in exchange for, and having substantially the same terms as, restricted stock units ("RSUs") of Mylan in connection with the Combination. F13 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. The RSUs will vest on March 2, 2021. F13 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. The RSUs will vest on March 2, 2021. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:52 UTC | Viatris Inc VTRS · Entity 3277 | GrantNon-Employee Director Stock Option - Right to Buy · Derivative | 6,151 | Not disclosed Strike: $17.48 | Not disclosed |
DisclosureSEC source: 0000899243-20-031576 · doc4.xml · derivative · entry 9 Lyons Dillon JoEllen · CIK 0001570168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,151 Underlying: Common Stock · 6,151 shares Expires 2030-03-02 F4 · security: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F4 · price: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F11 · derivative.exercise_date: These options will vest on March 2, 2021. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:52 UTC | Viatris Inc VTRS · Entity 3277 | GrantNon-Employee Director Stock Option - Right to Buy · Derivative | 4,352 | Not disclosed Strike: $27.45 | Not disclosed |
DisclosureSEC source: 0000899243-20-031576 · doc4.xml · derivative · entry 8 Lyons Dillon JoEllen · CIK 0001570168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,352 Underlying: Common Stock · 4,352 shares Expires 2029-03-01 F4 · security: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F4 · price: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F10 · derivative.exercise_date: These options vested on March 2, 2020. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:52 UTC | Viatris Inc VTRS · Entity 3277 | GrantNon-Employee Director Stock Option - Right to Buy · Derivative | 2,984 | Not disclosed Strike: $40.97 | Not disclosed |
DisclosureSEC source: 0000899243-20-031576 · doc4.xml · derivative · entry 7 Lyons Dillon JoEllen · CIK 0001570168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,984 Underlying: Common Stock · 2,984 shares Expires 2028-03-02 F4 · security: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F4 · price: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F9 · derivative.exercise_date: These options vested on March 2, 2019. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:52 UTC | Viatris Inc VTRS · Entity 3277 | GrantNon-Employee Director Stock Option - Right to Buy · Derivative | 2,928 | Not disclosed Strike: $45.18 | Not disclosed |
DisclosureSEC source: 0000899243-20-031576 · doc4.xml · derivative · entry 6 Lyons Dillon JoEllen · CIK 0001570168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,928 Underlying: Common Stock · 2,928 shares Expires 2027-03-03 F4 · security: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F4 · price: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F8 · derivative.exercise_date: These options vested on March 3, 2018. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:52 UTC | Viatris Inc VTRS · Entity 3277 | GrantNon-Employee Director Stock Option - Right to Buy · Derivative | 2,788 | Not disclosed Strike: $46.27 | Not disclosed |
DisclosureSEC source: 0000899243-20-031576 · doc4.xml · derivative · entry 5 Lyons Dillon JoEllen · CIK 0001570168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,788 Underlying: Common Stock · 2,788 shares Expires 2026-02-17 F4 · security: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F4 · price: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F7 · derivative.exercise_date: These options vested on February 17, 2017. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:52 UTC | Viatris Inc VTRS · Entity 3277 | GrantNon-Employee Director Stock Option - Right to Buy · Derivative | 2,603 | Not disclosed Strike: $50.66 | Not disclosed |
DisclosureSEC source: 0000899243-20-031576 · doc4.xml · derivative · entry 4 Lyons Dillon JoEllen · CIK 0001570168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,603 Underlying: Common Stock · 2,603 shares Expires 2025-11-17 F4 · security: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F4 · price: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F6 · derivative.exercise_date: These options vested on May 1, 2016. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:52 UTC | Viatris Inc VTRS · Entity 3277 | GrantNon-Employee Director Stock Option - Right to Buy · Derivative | 2,974 | Not disclosed Strike: $45.72 | Not disclosed |
DisclosureSEC source: 0000899243-20-031576 · doc4.xml · derivative · entry 3 Lyons Dillon JoEllen · CIK 0001570168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,974 Underlying: Common Stock · 2,974 shares Expires 2024-04-11 F4 · security: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F4 · price: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F5 · derivative.exercise_date: These options vested on April 11, 2015. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:52 UTC | Viatris Inc VTRS · Entity 3277 | GrantCommon Stock | 15,609 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-031576 · doc4.xml · nonDerivative · entry 1 Lyons Dillon JoEllen · CIK 0001570168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,609 F1 · security: On November 16, 2020, Mylan N.V. ("Mylan") completed the transaction pursuant to which Mylan combined with Pfizer Inc.'s ("Pfizer") Upjohn business (the "Upjohn Business") in a Reverse Morris Trust transaction (the "Combination") and Upjohn Inc. ("Upjohn") became the parent entity of the combined Upjohn Business and Mylan business and was renamed "Viatris Inc." ("Viatris"). Pursuant to the terms of the Business Combination Agreement (as amended), dated July 29, 2019, by and among Mylan, Pfizer, Upjohn and certain other affiliated entities, Upjohn and Mylan effected the Combination through a series of transactions, including that each holder of Mylan ordinary shares received one share of Viatris common stock for each Mylan ordinary share held by such holder (subject to any required withholding tax). F2 · price: Represents shares of Viatris common stock acquired in connection with the Combination on a one-for-one basis in exchange for ordinary shares of Mylan. On the effective date of the Combination, the closing price of a Mylan ordinary share was $15.85 per share. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:20 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerRestricted Stock Units · Derivative | 9,440 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000899243-20-031513 · doc4.xml · derivative · entry 9 Lyons Dillon JoEllen · CIK 0001570168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 9,440 shares Expires not disclosed F11 · security: Represents restricted stock units ("RSUs") of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms in connection with the Combination. F11 · price: Represents restricted stock units ("RSUs") of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms in connection with the Combination. F12 · derivative.exercise_date: Each RSU represents the right to receive one ordinary share of Mylan. The RSUs will vest on March 2, 2021. F12 · derivative.expiration_date: Each RSU represents the right to receive one ordinary share of Mylan. The RSUs will vest on March 2, 2021. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:20 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerNon-Employee Director Stock Option - Right to Buy · Derivative | 6,151 | Not disclosed Strike: $17.48 | Not disclosed |
DisclosureSEC source: 0000899243-20-031513 · doc4.xml · derivative · entry 8 Lyons Dillon JoEllen · CIK 0001570168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 6,151 shares Expires 2030-03-02 F3 · security: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F3 · price: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F10 · derivative.exercise_date: These options will vest on March 2, 2021. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:20 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerNon-Employee Director Stock Option - Right to Buy · Derivative | 4,352 | Not disclosed Strike: $27.45 | Not disclosed |
DisclosureSEC source: 0000899243-20-031513 · doc4.xml · derivative · entry 7 Lyons Dillon JoEllen · CIK 0001570168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 4,352 shares Expires 2029-03-01 F3 · security: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F3 · price: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F9 · derivative.exercise_date: These options vested on March 2, 2020. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:20 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerNon-Employee Director Stock Option - Right to Buy · Derivative | 2,984 | Not disclosed Strike: $40.97 | Not disclosed |
DisclosureSEC source: 0000899243-20-031513 · doc4.xml · derivative · entry 6 Lyons Dillon JoEllen · CIK 0001570168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,984 shares Expires 2028-03-02 F3 · security: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F3 · price: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F8 · derivative.exercise_date: These options vested on March 2, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.